• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

术后放疗在隆突性皮肤纤维肉瘤中的作用:倾向评分匹配分析。

Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis.

机构信息

Department of Radiation Oncology, Xiamen Humanity Hospital, Xiamen, 361000, China.

Department of Radiation Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou, 350014, China.

出版信息

Radiat Oncol. 2019 Jan 29;14(1):20. doi: 10.1186/s13014-019-1226-z.

DOI:10.1186/s13014-019-1226-z
PMID:30696463
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6350344/
Abstract

OBJECTIVE

This study aimed to evaluate the role of postoperative radiotherapy (RT) in dermatofibrosarcoma protuberans (DFSP) and identify the prognostic factors influencing the disease-free survival (DFS).

METHODS

A total of 184 patients with DFSP were analyzed from 2000 to 2016. The regression model was used to examine the prognostic factors for DFS. Baseline covariates were balanced using a propensity score model. The role of RT was assessed by comparing the DFS of the surgery + RT group with that of the surgery group.

RESULTS

The median follow-up was 58 months (range, 6-203 months). The 5-year DFS rate was 89.8%. The univariate analysis showed that age ≥ 50 years, presence of fibrosarcoma, margins < 2 cm, and tumor size ≥5 cm were associated with worse DFS (P = 0.002, P <  0.001, P = 0.030, and P = 0.032, respectively). The multivariate Cox regression model revealed that age, margin width, lesion number, and histological subtype independently affected DFS. The Ki-67 expression was related to age and histological subtype. Patients with Ki-67 ≥ 17% showed a worse DFS than those with Ki-67 < 17% (35.8% vs 87.8%, P = 0.002). In the matched cohort, DFS was significantly higher in the S + RT group than in the S group (5-year DFS, 88.1% vs 56.2%, P = 0.044).

CONCLUSIONS

Age, margin width, lesion number, and histological subtype were independent risk factors for DFS in patients with DFSP. The high expression of Ki-67 could predict a poor prognosis. Postoperative RT could improve DFS for patients with DFSP.

摘要

目的

本研究旨在评估术后放疗(RT)在隆突性皮肤纤维肉瘤(DFSP)中的作用,并确定影响无病生存(DFS)的预后因素。

方法

对 2000 年至 2016 年间的 184 例 DFSP 患者进行分析。采用回归模型分析影响 DFS 的预后因素。采用倾向评分模型平衡基线协变量。通过比较手术+RT 组与手术组的 DFS,评估 RT 的作用。

结果

中位随访时间为 58 个月(范围,6-203 个月)。5 年 DFS 率为 89.8%。单因素分析显示,年龄≥50 岁、存在纤维肉瘤、切缘<2cm 和肿瘤大小≥5cm 与较差的 DFS 相关(P=0.002、P<0.001、P=0.030 和 P=0.032)。多因素 Cox 回归模型显示,年龄、切缘宽度、病变数量和组织学亚型独立影响 DFS。Ki-67 表达与年龄和组织学亚型有关。Ki-67≥17%的患者DFS 较 Ki-67<17%的患者差(35.8%比 87.8%,P=0.002)。在匹配队列中,S+RT 组的 DFS 明显高于 S 组(5 年 DFS,88.1%比 56.2%,P=0.044)。

结论

年龄、切缘宽度、病变数量和组织学亚型是 DFSP 患者 DFS 的独立危险因素。Ki-67 高表达可预测不良预后。术后 RT 可改善 DFSP 患者的 DFS。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/4d5211d7ceb2/13014_2019_1226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/4901c46515af/13014_2019_1226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/2d988158e076/13014_2019_1226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/4d5211d7ceb2/13014_2019_1226_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/4901c46515af/13014_2019_1226_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/2d988158e076/13014_2019_1226_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed12/6350344/4d5211d7ceb2/13014_2019_1226_Fig3_HTML.jpg

相似文献

1
Role of postoperative radiotherapy in dermatofibrosarcoma protuberans: a propensity score-matched analysis.术后放疗在隆突性皮肤纤维肉瘤中的作用:倾向评分匹配分析。
Radiat Oncol. 2019 Jan 29;14(1):20. doi: 10.1186/s13014-019-1226-z.
2
Radiotherapy in the treatment of dermatofibrosarcoma protuberans.放射疗法在隆突性皮肤纤维肉瘤治疗中的应用
Am J Clin Oncol. 2005 Dec;28(6):537-9. doi: 10.1097/01.coc.0000171278.69291.64.
3
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.隆突性皮肤纤维肉瘤:53 例接受保守手术和放射治疗患者的长期结果。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):585-90. doi: 10.1016/j.ijrobp.2013.02.024. Epub 2013 Apr 26.
4
Long-term outcomes of surgical treatment for dermatofibrosarcoma protuberans according to width of gross resection margin.根据大体切除边缘宽度分析隆突性皮肤纤维肉瘤手术治疗的长期疗效
J Plast Reconstr Aesthet Surg. 2016 Mar;69(3):395-401. doi: 10.1016/j.bjps.2015.10.027. Epub 2015 Oct 30.
5
Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.隆突性皮肤纤维肉瘤:对在单一机构接受治疗及随访的患者的临床病理分析
Cancer. 2000 Jun 15;88(12):2711-20.
6
Radiotherapy for dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤的放射治疗
Am J Clin Oncol. 2014 Oct;37(5):430-2. doi: 10.1097/COC.0b013e31827dee86.
7
Dermatofibrosarcoma protuberans.隆突性皮肤纤维肉瘤
Cancer. 2004 Dec 1;101(11):2503-8. doi: 10.1002/cncr.20678.
8
A single-institutional review of 68 patients with dermatofibrosarcoma protuberans: wide re-excision after inadequate previous surgery results in a high rate of local control.一项针对68例隆突性皮肤纤维肉瘤患者的单机构回顾性研究:先前手术不充分后进行广泛再次切除可实现较高的局部控制率。
World J Surg Oncol. 2017 Jan 5;15(1):5. doi: 10.1186/s12957-016-1075-2.
9
Evaluation of the role of radiotherapy in the management of dermatofibrosarcoma protuberans.放射治疗在隆突性皮肤纤维肉瘤治疗中作用的评估。
J BUON. 2013 Jan-Mar;18(1):268-73.
10
Low recurrence rate after surgery for dermatofibrosarcoma protuberans: a multidisciplinary approach from a single institution.隆突性皮肤纤维肉瘤手术后的低复发率:来自单一机构的多学科方法。
Cancer. 2004 Mar 1;100(5):1008-16. doi: 10.1002/cncr.20051.

引用本文的文献

1
Successful treatment of metastatic dermatofibrosarcoma protuberans of the breast to the lungs with imatinib mesylate: a case report.甲磺酸伊马替尼成功治疗乳腺隆突性皮肤纤维肉瘤肺转移:1例报告
Ecancermedicalscience. 2025 May 27;19:1912. doi: 10.3332/ecancer.2025.1912. eCollection 2025.
2
Dermatofibrosarcoma Protuberans in a 12-Year-Old Child: A Rare Case.一名12岁儿童的隆突性皮肤纤维肉瘤:罕见病例
Clin Cosmet Investig Dermatol. 2024 Aug 27;17:1921-1930. doi: 10.2147/CCID.S480616. eCollection 2024.
3
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review.

本文引用的文献

1
Dermatofibrosarcoma protuberans: when the age makes the difference.隆突性皮肤纤维肉瘤:年龄所产生的影响
G Ital Dermatol Venereol. 2018 Jun;153(3):344-348. doi: 10.23736/S0392-0488.17.05435-9. Epub 2017 May 16.
2
The efficacy of adjuvant radiotherapy in dermatofibrosarcoma protuberans: a systemic review and meta-analysis.辅助放疗在隆突性皮肤纤维肉瘤中的疗效:系统评价和荟萃分析。
J Eur Acad Dermatol Venereol. 2016 Jul;30(7):1107-14. doi: 10.1111/jdv.13601. Epub 2016 Feb 16.
3
Number of negative lymph nodes should be considered for incorporation into staging for breast cancer.
术后放疗在隆突性皮肤纤维肉瘤治疗中的作用:一项多学科系统评价
J Clin Med. 2024 Mar 21;13(6):1798. doi: 10.3390/jcm13061798.
4
Dermatofibrosarcoma protuberans: a case report of an abdominal wall mass and review of the literature.隆突性皮肤纤维肉瘤:腹壁肿块病例报告及文献复习
J Surg Case Rep. 2023 Oct 6;2023(10):rjad542. doi: 10.1093/jscr/rjad542. eCollection 2023 Oct.
5
Long-Term Outcome of Neoadjuvant Tyrosine Kinase Inhibitors Followed by Complete Surgery in Locally Advanced Dermatofibrosarcoma Protuberans.新辅助酪氨酸激酶抑制剂治疗后行根治性手术的局部晚期隆突性皮肤纤维肉瘤的长期预后
Cancers (Basel). 2021 May 6;13(9):2224. doi: 10.3390/cancers13092224.
6
A Rare Malignant Disease, Dermatofibrosarcoma Protuberans of the Breast: A Retrospective Analysis and Review of Literature.罕见恶性疾病,乳腺隆突性皮肤纤维肉瘤:回顾性分析及文献复习。
Biomed Res Int. 2020 Nov 9;2020:8852182. doi: 10.1155/2020/8852182. eCollection 2020.
7
The Ki-67 proliferation index predicts recurrence-free survival in patients with dermatofibrosarcoma protuberans.Ki-67 增殖指数可预测隆突性皮肤纤维肉瘤患者的无复发生存。
Bosn J Basic Med Sci. 2021 Apr 1;21(2):174-178. doi: 10.17305/bjbms.2020.5088.
8
Dermatofibrosarcoma metastases to the pancreas: A case report.皮肤纤维肉瘤转移至胰腺:一例报告。
World J Clin Cases. 2019 Oct 26;7(20):3316-3321. doi: 10.12998/wjcc.v7.i20.3316.
应考虑将阴性淋巴结数量纳入乳腺癌分期。
Am J Cancer Res. 2015 Jan 15;5(2):844-53. eCollection 2015.
4
Dermatofibrosarcoma protuberans in children and adolescents: Clinical presentation, histology, treatment, and review of the literature.儿童和青少年隆突性皮肤纤维肉瘤:临床表现、组织病理学、治疗及文献复习。
J Plast Reconstr Aesthet Surg. 2014 Sep;67(9):1222-9. doi: 10.1016/j.bjps.2014.05.031. Epub 2014 Jun 2.
5
A systematic review of outcome data for dermatofibrosarcoma protuberans with and without fibrosarcomatous change.隆突性皮肤纤维肉瘤伴和不伴纤维肉瘤样变的结局数据的系统评价。
J Am Acad Dermatol. 2014 Oct;71(4):781-6. doi: 10.1016/j.jaad.2014.03.018. Epub 2014 Apr 19.
6
Dermatofibrosarcoma protuberans: clinical series, national Danish incidence data and suggested guidelines.隆突性皮肤纤维肉瘤:临床系列、丹麦全国发病率数据及建议指南。
J Plast Surg Hand Surg. 2014 Feb;48(1):67-73. doi: 10.3109/2000656X.2013.812969. Epub 2013 Jul 9.
7
Dermatofibrosarcoma protuberans: long-term outcomes of 53 patients treated with conservative surgery and radiation therapy.隆突性皮肤纤维肉瘤:53 例接受保守手术和放射治疗患者的长期结果。
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):585-90. doi: 10.1016/j.ijrobp.2013.02.024. Epub 2013 Apr 26.
8
Dermatofibrosarcoma protuberans: a comprehensive review and update on diagnosis and management.隆突性皮肤纤维肉瘤:诊断与治疗的全面综述及更新。
Semin Diagn Pathol. 2013 Feb;30(1):13-28. doi: 10.1053/j.semdp.2012.01.002.
9
Multidisciplinary approach to the management of dermatofibrosarcoma protuberans.多学科方法治疗隆突性皮肤纤维肉瘤。
J Am Acad Dermatol. 2012 Nov;67(5):861-6. doi: 10.1016/j.jaad.2012.01.039. Epub 2012 Mar 2.
10
Dermatofibrosarcoma protuberans: clinical diagnoses and treatment results of 260 cases in China.隆突性皮肤纤维肉瘤:中国 260 例临床诊断和治疗结果。
J Surg Oncol. 2012 Feb;105(2):142-8. doi: 10.1002/jso.22000. Epub 2011 Aug 3.